Fluoxymesterone (Halotestin)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 18:02, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Discontinued" to "Category:Discontinued drugs")
Jump to navigation Jump to search

Mechanism of action

Androgen and anabolic steroid

Diseases for which it is used

History of changes in FDA indication

  • 10/15/1956: Initial FDA approval

Also known as

  • Brand names: Halotestin, Ultandren
Retrieved from "https://hemonc.org/w/index.php?title=Fluoxymesterone_(Halotestin)&oldid=35530"